KKR Debuts Engineered Solutions Platform for Medtech and Precision Industries

KKR has launched Allyntra, a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform.

KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.

Robbie Atkinson has taken charge of Allyntra as CEO and Brian Highley is the chairman. The pair bring deep experience building and scaling global manufacturing organizations through operational excellence and strategic leadership. Most recently, Atkinson was CEO and president of Medical Manufacturing Technologies (MMT), where he led the company’s strategy, operations, and growth through a period of significant expansion, culminating in its sale to Perimeter Solutions Inc.

“The pace of innovation across medical technology and other highly engineered industries continues to accelerate,” Atkinson stated. “As these technologies become more sophisticated, customers are looking for partners who can help them move faster, solve increasingly complex challenges, and bring new ideas to life. That’s exactly the opportunity I see for Allyntra.”

Highley has more than 30 years of experience in the medical technology industry, having previously served as CEO of Cirtec, where he scaled the company meaningfully from two sites into one a provider of end-to-end services to medical technology OEMs, including design, engineering, prototyping, and manufacturing solutions.

“Throughout my career, I’ve learned that the companies that endure are the ones that combine technical excellence with a willingness to continue evolving alongside their customers,” Highley said. “Those are the qualities I believe will define Allyntra, and I’m excited to help shape its future by working alongside Robbie and the team.”

As part of this platform launch, Oliver Laubscher will join the Allyntra Board of Directors and transition from his role as Precipart CEO. 

“For more than 70 years, Precipart has earned its customers’ trust through engineering excellence, innovation, and a relentless focus on quality,” Laubscher commented. “I look forward to continuing to work with KKR, Robbie, and Brian to support Allyntra’s next chapter of growth—building on our legacy and the culture that built it and furthering our mission to help customers “engineer possible.”

“Our deepened commitment to Allyntra reflects our confidence in the market opportunity and Robbie’s and Brian’s ability to bring the Allyntra vision to life. Since first investing in Precipart in 2023, we’ve become increasingly convinced of the opportunity to create a distinctive precision-engineered solutions platform. We’re pleased to continue our strategic partnership with the Laubscher family, who will remain a meaningful shareholder,” said Ali Satvat, global head of Health Care Strategic Growth and co-head of Americas Private Equity Health Care at KKR, and Anuv Ratan, managing director at KKR. 

KKR is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient, disciplined investment approach, supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit, and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life, and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries.

Allyntra is an engineered solutions partner to the medical technology industry, specializing in the design, development, and manufacture of highly engineered components and assemblies for advanced surgical applications. Allyntra collaborates with medtech innovators to accelerate the development and commercialization of next-generation technologies, including robotic-assisted surgery, minimally invasive surgery, and advanced surgical systems.